Cargando…
Pharmacological and immunological effects of praziquantel against Schistosoma japonicum: a scoping review of experimental studies
BACKGROUND: Chemotherapy for schistosomiasis has been around for 100 years. During the past century, great efforts have been made to develop new antischistosomal drugs from antimonials to nonantimonials, and some of these have been used extensively in clinical treatment. With the exception of a few...
Autores principales: | Xiao, Shu-Hua, Sun, Jun, Chen, Ming-Gang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5801800/ https://www.ncbi.nlm.nih.gov/pubmed/29409536 http://dx.doi.org/10.1186/s40249-018-0391-x |
Ejemplares similares
-
Assessment of morbidity due to Schistosoma japonicum infection in China
por: Chen, Ming-gang
Publicado: (2014) -
Synthesis and SAR Studies of Praziquantel Derivatives with Activity against Schistosoma japonicum
por: Wang, Wen-Long, et al.
Publicado: (2013) -
New Insight into the Antifibrotic Effects of Praziquantel on Mice in Infection with Schistosoma japonicum
por: Liang, Yue-Jin, et al.
Publicado: (2011) -
Controlling schistosomiasis with praziquantel: How much longer without a viable alternative?
por: Bergquist, Robert, et al.
Publicado: (2017) -
Population Pharmacokinetics of Praziquantel in Pregnant and Lactating Filipino Women Infected with Schistosoma japonicum
por: Bustinduy, Amaya L., et al.
Publicado: (2020)